D-dimer Blood Test

The Role of D-dimer in Hemostasis Testing

Determination of D-dimer levels is rarely performed in isolation; as a rule, this parameter is part of a screening coagulation profile, the coagulogram. A direct indication for ordering this panel is a detected decrease in the platelet count on a complete blood count (CBC). The primary goal of such testing is to objectively assess the risk of bleeding complications.

In addition to the D-dimer concentration, the mandatory diagnostic minimum includes:

• Thrombin time.
• Prothrombin Time (PT).
• International Normalized Ratio (INR).
• Activated partial thromboplastin time (APTT).
• Fibrinogen.

In an extended panel, the investigation may include assessing the activity of antithrombin III and plasminogen.

It is important to note that regular coagulogram testing is not always mandatory. Similar to a routine urinalysis, hemostasis testing may be omitted during follow-up outpatient visits, routine check-ups, assessment of remission status, suspected disease recurrence, or prior to initiating a new cycle of therapy. The primary condition for omitting the test is the complete absence of clinical signs of a coagulation disorder in the patient.

Role in the Diagnosis of Deep Vein Thrombosis (DVT)

In clinical practice, the D-dimer test is of paramount importance in the diagnosis of deep vein thrombosis. Measuring its concentration serves as a full-fledged alternative to initial ultrasound examination in situations where the patient presents with clinical signs of thrombosis.

The correct interpretation of the results is as follows:

1. Normal Value: If the marker level is within the normal range, a diagnosis of DVT is ruled out with an extremely high degree of probability.
2. Elevated Value: The detection of a high concentration is a strict indication for immediately referring the patient for instrumental diagnostics.

Confirmatory methods include lower extremity venous duplex scanning or comprehensive triplex scanning covering the inferior vena cava, iliac veins, and the venous bed of the lower extremities.

D-dimer in DIC

Disseminated intravascular coagulation (DIC) is a severe complication that in rare cases may develop, for example, in the setting of West Nile fever.

The laboratory picture of this pathology shows specific changes on the coagulogram. Key signs of DIC include:

• A sharp increase in D-dimer concentration.
• A significant decrease in fibrinogen levels.
• Pathological prolongation of prothrombin time (PT) and aPTT.

Connection to Urologic Oncology and Therapy Monitoring

Coagulogram components are also used in other pathologies. For example, hemostasis testing is mandatory for all patients with suspected upper tract urothelial carcinoma (UTUC) to assess risks and select treatment tactics.

When prescribing anticoagulant therapy, strict laboratory monitoring is also required; however, physicians rely on other coagulogram parameters rather than D-dimer:

• Unfractionated heparin (UFH) therapy is monitored by measuring aPTT.
• The use of vitamin K antagonists requires strict INR monitoring.
• The use of low-molecular-weight heparins (enoxaparin, dalteparin, nadroparin, bemiparin, parnaparin) and UFH may require evaluating the individual patient response by measuring anti-Xa activity.

A mandatory condition for the dynamic monitoring of any anticoagulant therapy is the calculation of creatinine clearance, as well as monitoring baseline parameters of a complete blood count and biochemical blood analysis.

Class and exam questions

What else to study on this topic

• Monitoring anti-Xa activity during low-molecular-weight heparin therapy.
• Assessing creatinine clearance when prescribing anticoagulants.
• Laboratory monitoring of vitamin K antagonist therapy (INR control).
• Specifics of laboratory diagnostics when upper tract urothelial carcinoma is suspected.

Prepared by WhiteCoat Pro faculty in accordance with the medical school curriculum. For educational purposes only.